支氣管炎治療市場：按類型（急性支氣管炎、慢性支氣管炎）、治療劑（藥物、氧氣療法）、藥物類別、最終用戶 - 2023-2030 年全球預測

全球支氣管炎治療市場預計將大幅成長，預計2023年將達到67.2122億美元，年複合成長率為6.73%，2030年將達到106.204億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球支氣管炎治療市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.支氣管炎治療的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球支氣管炎治療市場的阻礙因素與影響有哪些？

3.在預測期內，全球支氣管炎治療市場需要投資哪些產品/細分市場/應用/領域？

4. 全球支氣管炎治療市場的競爭策略為何？

5. 全球支氣管炎治療市場的技術趨勢和法律規範是什麼？

6.全球支氣管炎治療市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球支氣管炎治療市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 支氣管炎發生率迅速上升導致老年人口增加
    • COPD 患者盛行率增加
    • 人們對支氣管炎的認知不斷提高
  • 抑制因素
    • 藥品專利到期
  • 機會
    • 慢性阻塞性肺病治療的進展，包括合併療法和小細胞療法
    • 與政府合作，提高新興經濟體治療的認知和市場滲透率
  • 任務
    • 與氧氣療法相關的風險和副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 支氣管炎治療市場：依類型

• 急性支氣管炎
• 慢性支氣管炎

第7章 依治療分類的支氣管炎治療市場

• 藥品
• 氧氣療法

第8章 按藥物類別分類的支氣管炎治療市場

• 發炎藥
• 抗生素
• 支氣管擴張劑

第9章 支氣管炎治療市場：依最終用戶分類

• 診所
• 醫院藥房
• 零售藥房

第10章 美洲支氣管炎治療市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太支氣管炎治療市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲支氣管炎治療市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Bronchitis Treatment Market is forecasted to grow significantly, with a projected USD 6,721.22 million in 2023 at a CAGR of 6.73% and expected to reach a staggering USD 10,620.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Bronchitis Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Bronchitis Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Acute Bronchitis and Chronic Bronchitis. The Acute Bronchitis is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Drugs and Oxygen Therapy. The Drugs is projected to witness significant market share during forecast period.

Based on Class of Drugs, market is studied across Anti-inflammatory Drugs, Antibiotics, and Bronchodilator. The Antibiotics is projected to witness significant market share during forecast period.

Based on End User, market is studied across Clinics, Hospital Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Bronchitis Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bronchitis Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bronchitis Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bronchitis Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Bronchitis Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Bronchitis Treatment Market?

6. What is the market share of the leading vendors in the Global Bronchitis Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Bronchitis Treatment Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Bronchitis Treatment Market, by Type, 2022 vs 2030
• 4.3. Bronchitis Treatment Market, by Treatment, 2022 vs 2030
• 4.4. Bronchitis Treatment Market, by Class of Drugs, 2022 vs 2030
• 4.5. Bronchitis Treatment Market, by End User, 2022 vs 2030
• 4.6. Bronchitis Treatment Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in geriatric population with surge in incidence of bronchitis
    • 5.1.1.2. Rising prevalence of COPD patients
    • 5.1.1.3. Rising awareness regarding bronchitis
  • 5.1.2. Restraints
    • 5.1.2.1. Patent expiry of drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in the COPD therapies such as combination therapies and small cell therapy
    • 5.1.3.2. Collaborative initiatives with government for treatment awareness and market penetration in developing economies
  • 5.1.4. Challenges
    • 5.1.4.1. Risk and side effects associated with oxygen therapy
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Bronchitis Treatment Market, by Type

• 6.1. Introduction
• 6.2. Acute Bronchitis
• 6.3. Chronic Bronchitis

7. Bronchitis Treatment Market, by Treatment

• 7.1. Introduction
• 7.2. Drugs
• 7.3. Oxygen Therapy

8. Bronchitis Treatment Market, by Class of Drugs

• 8.1. Introduction
• 8.2. Anti-inflammatory Drugs
• 8.3. Antibiotics
• 8.4. Bronchodilator

9. Bronchitis Treatment Market, by End User

• 9.1. Introduction
• 9.2. Clinics
• 9.3. Hospital Pharmacies
• 9.4. Retail Pharmacies

10. Americas Bronchitis Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Bronchitis Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Bronchitis Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BRONCHITIS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. BRONCHITIS TREATMENT MARKET SIZE, 2022 VS 2030
• FIGURE 3. BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
• FIGURE 6. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2022 VS 2030 (%)
• FIGURE 7. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 8. BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. BRONCHITIS TREATMENT MARKET DYNAMICS
• FIGURE 10. BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BRONCHITIS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. BRONCHITIS TREATMENT MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BRONCHITIS TREATMENT MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. BRONCHITIS TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BRONCHITIS TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 11. BRONCHITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 55. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 56. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 59. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 60. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 128. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 129. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 144. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 145. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 148. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 149. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 187. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 188. BRONCHITIS TREATMENT MARKET LICENSE & PRICING